Artificial intelligence continues to reshape biotechnology and healthcare delivery. Google DeepMind’s AlphaGenome model integrates multimodal genomic predictions to advance variant effect analysis. Lunit and Microsoft partner to co-develop cloud-based clinical AI solutions, expanding diagnostics and treatment support. AI-assistance enhances pathologists’ accuracy in tumor tissue evaluation. Further, CMS has established reimbursement rates for Eko Health’s AI platform targeting cardiac diagnoses, underlining increasing regulatory acceptance of AI tools in clinical settings.